• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心力衰竭相关性胸腔积液诊断预测模型的开发与验证:BANCA评分

Development and validation of a diagnostic prediction model for heart failure-related pleural effusions: the BANCA score.

作者信息

Porcel José M, Trujillano Javier, Porcel Laura, Esquerda Aureli, Bielsa Silvia

机构信息

Pleural Medicine and Clinical Ultrasound Unit, Department of Internal Medicine, Arnau de Vilanova University Hospital, IRBLleida, Lleida, Spain.

Department of Intensive Care Unit, Arnau de Vilanova University Hospital, Lleida, Spain.

出版信息

ERJ Open Res. 2025 Jun 30;11(3). doi: 10.1183/23120541.01030-2024. eCollection 2025 May.

DOI:10.1183/23120541.01030-2024
PMID:40589901
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12208600/
Abstract

AIM

Heart failure (HF) is a common cause of pleural effusion (PE); however, its diagnosis can be challenging owing to overlapping clinical features with other causes. Measuring N-terminal pro-brain natriuretic peptide (NT-proBNP) levels is diagnostically useful, but the optimal cut-off point must be determined. This study aimed to optimise NT-proBNP cut-offs for diagnosing HF-related PEs and develop a scoring model to improve diagnostic precision.

METHODS

A retrospective analysis was conducted on 2005 patients with PEs, who were divided into derivation and validation cohorts. Receiver operating characteristic curve analysis identified the optimal cut-off point for NT-proBNP in pleural fluid and serum. A scoring system was developed based on logistic regression (TRIPOD statement) that included both clinical and laboratory variables. Its diagnostic accuracy was compared with that of existing methods using the area under the curve (AUC).

RESULTS

NT-proBNP ≥2500 pg·mL was found to be the optimal cut-off for identifying HF-related effusions. Pleural fluid NT-proBNP levels tended to have superior diagnostic accuracy compared with serum NT-proBNP levels. A scoring system, denominated as BANCA (bilateral effusions on chest radiographs, age, NT-proBNP levels in pleural fluid, cholesterol in pleural fluid, and albumin gradient), demonstrated an AUC of 0.957, outperforming existing diagnostic criteria for identifying cardiac effusions. In cases misclassified as exudates by Light's criteria, the BANCA score accurately identified 80% of the HF-related PEs.

CONCLUSIONS

The BANCA score is a reliable tool for diagnosing HF-related PEs, offering superior accuracy compared with conventional methods. It is particularly useful for identifying cardiac effusions that are misclassified using traditional criteria.

摘要

目的

心力衰竭(HF)是胸腔积液(PE)的常见病因;然而,由于其临床特征与其他病因重叠,其诊断可能具有挑战性。测量N末端脑钠肽前体(NT-proBNP)水平有助于诊断,但必须确定最佳截断点。本研究旨在优化用于诊断HF相关PE的NT-proBNP截断值,并开发一种评分模型以提高诊断准确性。

方法

对2005例PE患者进行回顾性分析,将其分为推导队列和验证队列。通过受试者工作特征曲线分析确定胸腔积液和血清中NT-proBNP的最佳截断点。基于逻辑回归(TRIPOD声明)开发了一个评分系统,该系统包括临床和实验室变量。使用曲线下面积(AUC)将其诊断准确性与现有方法进行比较。

结果

发现NT-proBNP≥2500 pg·mL是识别HF相关积液的最佳截断值。与血清NT-proBNP水平相比,胸腔积液NT-proBNP水平的诊断准确性往往更高。一个名为BANCA(胸部X线片双侧积液、年龄、胸腔积液NT-proBNP水平、胸腔积液胆固醇和白蛋白梯度)的评分系统显示AUC为0.957,优于现有诊断心脏积液的标准。在根据Light标准被误分类为渗出液的病例中,BANCA评分准确识别了80%的HF相关PE。

结论

BANCA评分是诊断HF相关PE的可靠工具,与传统方法相比具有更高的准确性。它对于识别使用传统标准误分类的心脏积液特别有用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cf3/12208600/b238d258b58b/01030-2024.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cf3/12208600/b238d258b58b/01030-2024.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cf3/12208600/b238d258b58b/01030-2024.01.jpg

相似文献

1
Development and validation of a diagnostic prediction model for heart failure-related pleural effusions: the BANCA score.心力衰竭相关性胸腔积液诊断预测模型的开发与验证:BANCA评分
ERJ Open Res. 2025 Jun 30;11(3). doi: 10.1183/23120541.01030-2024. eCollection 2025 May.
2
Brain natriuretic peptide and N-terminal brain natriuretic peptide for the diagnosis of haemodynamically significant patent ductus arteriosus in preterm neonates.脑利钠肽和 N 末端脑利钠肽在诊断早产儿血液动力学意义未闭动脉导管中的应用。
Cochrane Database Syst Rev. 2022 Dec 8;12(12):CD013129. doi: 10.1002/14651858.CD013129.pub2.
3
The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all-cause mortality in patients who undergo noncardiac surgery.生物标志物对改良心脏风险指数在预测非心脏手术患者主要不良心脏事件和全因死亡率方面的比较和附加预后价值。
Cochrane Database Syst Rev. 2021 Dec 21;12(12):CD013139. doi: 10.1002/14651858.CD013139.pub2.
4
Evidence-Based Application of Natriuretic Peptides in the Evaluation of Chronic Heart Failure With Preserved Ejection Fraction in the Ambulatory Outpatient Setting.利钠肽在门诊环境中评估射血分数保留的慢性心力衰竭中的循证应用
Circulation. 2025 Apr 8;151(14):976-989. doi: 10.1161/CIRCULATIONAHA.124.072156. Epub 2025 Jan 22.
5
Comparing serum and pleural fluid pro-brain natriuretic peptide (NT-proBNP) levels with pleural-to-serum albumin gradient for the identification of cardiac effusions misclassified by Light's criteria.比较血清和胸腔积液中脑钠肽前体(NT-proBNP)水平与胸腔积液-血清白蛋白梯度,以识别被Light标准误分类的心脏积液。
Respirology. 2007 Sep;12(5):654-9. doi: 10.1111/j.1440-1843.2007.01109.x.
6
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
7
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
8
Testing for BNP and NT-proBNP in the diagnosis and prognosis of heart failure.B型利钠肽(BNP)和N末端B型利钠肽原(NT-proBNP)检测在心力衰竭诊断和预后评估中的应用
Evid Rep Technol Assess (Full Rep). 2006 Sep(142):1-147.
9
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
10
Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care.心力衰竭诊断的系统评价和个体患者数据荟萃分析,以及对初级保健中不同诊断策略影响的建模。
Health Technol Assess. 2009 Jul;13(32):1-207, iii. doi: 10.3310/hta13320.

本文引用的文献

1
ERS statement on benign pleural effusions in adults.欧洲呼吸学会关于成人良性胸腔积液的声明。
Eur Respir J. 2024 Jul 26;64(6). doi: 10.1183/13993003.02307-2023. Print 2024 Dec.
2
DUETS for Light's in separating exudate from transudate.双杯法用于分离渗出液和漏出液。
Respirology. 2024 Nov;29(11):976-984. doi: 10.1111/resp.14780. Epub 2024 Jul 3.
3
British Thoracic Society Guideline for pleural disease.英国胸科学会胸膜疾病指南。
Thorax. 2023 Jul;78(Suppl 3):s1-s42. doi: 10.1136/thorax-2022-219784.
4
Expert Review on Contemporary Management of Common Benign Pleural Effusions.常见良性胸腔积液的当代管理专家综述
Semin Respir Crit Care Med. 2023 Aug;44(4):477-490. doi: 10.1055/s-0043-1769096. Epub 2023 Jun 1.
5
Nonmalignant Pleural Effusions.非恶性胸腔积液。
Semin Respir Crit Care Med. 2022 Aug;43(4):570-582. doi: 10.1055/s-0042-1748186. Epub 2022 Sep 14.
6
Development and validation of a decision support tool for the diagnosis of acute heart failure: systematic review, meta-analysis, and modelling study.开发和验证用于急性心力衰竭诊断的决策支持工具:系统评价、荟萃分析和建模研究。
BMJ. 2022 Jun 13;377:e068424. doi: 10.1136/bmj-2021-068424.
7
Pleural Fluid Analysis: Are Light's Criteria Still Relevant After Half a Century?胸腔积液分析:半个世纪后,Light 标准仍然适用吗?
Clin Chest Med. 2021 Dec;42(4):599-609. doi: 10.1016/j.ccm.2021.07.003.
8
Pleural effusions in acute decompensated heart failure: Prevalence and prognostic implications.急性失代偿性心力衰竭中的胸腔积液:患病率和预后意义。
Eur J Intern Med. 2018 Jun;52:49-53. doi: 10.1016/j.ejim.2018.02.004. Epub 2018 Feb 7.
9
Development and validation of a scoring system for the identification of pleural exudates of cardiac origin.开发并验证一种评分系统,以识别心源性胸腔渗出液。
Eur J Intern Med. 2018 Apr;50:60-64. doi: 10.1016/j.ejim.2017.11.008. Epub 2017 Nov 20.
10
Safe and Effective Bedside Thoracentesis: A Review of the Evidence for Practicing Clinicians.安全有效的床边胸腔穿刺术:临床医生实践证据综述
J Hosp Med. 2017 Apr;12(4):266-276. doi: 10.12788/jhm.2716.